Learn More
The Australian Imaging, Biomarkers and Lifestyle (AIBL) study of aging, a participant of the worldwide Alzheimer's Disease Neuroimaging Initiative (ADNI), performed (11)C-Pittsburgh Compound B (PiB) scans in 177 healthy controls (HC), 57 mild cognitive impairment (MCI) subjects, and 53 mild Alzheimer's disease (AD) patients. High PiB binding was present in(More)
Accurate cortical thickness estimation is important for the study of many neurodegenerative diseases. Many approaches have been previously proposed, which can be broadly categorised as mesh-based and voxel-based. While the mesh-based approaches can potentially achieve subvoxel resolution, they usually lack the computational efficiency needed for clinical(More)
OBJECTIVE To investigate whether global and regional beta-amyloid (Abeta) burden as measured with 11C Pittsburgh compound B (PIB) PET is associated with hippocampal atrophy characterized using MRI in healthy controls and patients with amnestic mild cognitive impairment (aMCI) or Alzheimer disease (AD). METHODS Ninety-two elderly healthy controls, 32(More)
Beta-amyloid (Abeta) deposition is one of the neuropathological hallmarks of Alzheimer's disease (AD), Abeta burden can be quantified using (11)C PiB PET. Neuropathological studies have shown that the initial plaques are located in the temporal and orbitofrontal cortices, extending later to the cingulate, frontal and parietal cortices (Braak and Braak,(More)
Despite the increasing adoption of other imaging modalities, ultrasound guidance is widely used for surgical procedures and clinical imaging due to its low cost, non-invasiveness, and real-time visual feedback. Many ultrasound-guided procedures require extensive training and where possible training on simulations should be preferred over patients.(More)
We report in this communication a new formulation for the cost function of the well-known fuzzy C-means classification technique whereby we introduce weights. We derive the equations of this new weighted fuzzy C-means algorithm (WFCM) in the presence of additive and multiplicative bias field. We show that the weights can be designed in the same manner as(More)
Beta-amyloid (Abeta) plaques are one of the neuropathological hallmarks of Alzheimer's disease (AD) and can be quantified using the marker 11C PiB. As l1C PiB PET images have limited anatomical information, an Magnetic Resonance Image (MRI) is usually acquired to perform the spatial normalization needed for population analysis. We designed and evaluated a(More)
In magnetic resonance imaging (MRI), accuracy and precision with which brain structures may be quantified are frequently affected by the partial volume (PV) effect. PV is due to the limited spatial resolution of MRI compared to the size of anatomical structures. Accurate classification of mixed voxels and correct estimation of the proportion of each pure(More)
IMPORTANCE β-amyloid (Aβ) deposition is one of the hallmarks of Alzheimer disease. Aβ deposition accelerates gray matter atrophy at early stages of the disease even before objective cognitive impairment is manifested. Identification of at-risk individuals at the presymptomatic stage has become a major research interest because it will allow early(More)
RATIONALE AND OBJECTIVES Radiotracers such as (11)C-PiB have enabled the in vivo imaging of amyloid-beta plaques in the brain, one of the histopathologic hallmarks of Alzheimer's disease (AD). Standardized uptake value ratio (SUVR) has become the most common normalization for (11)C-PiB as it does not require dynamic scans or blood sampling. Normalization is(More)